Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Pigs

Immunological veterinary medicinal products, including vaccines, are authorised for pigs.

Search results 76 to 84 from a total of 84

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Pestiffa CL

Klassische Schweinepest

Boehringer Ingelheim Vetmedica GmbH

ESP-L 4/84 09.12.2019 Schwein

Ingelvac MycoFLEX Injektionssuspension

Enzootische Pneumonie

Boehringer Ingelheim Vetmedica GmbH

PEI.V.04758.01.1 12.05.2009 Schwein

Ingelvac PRRSFLEX EU

PRRS

Boehringer Ingelheim Vetmedica GmbH

PEI.V.11722.01.1 19.03.2015 Schwein

Enterisol Ileitis

Lawsonia intracellularis-Infektion

Boehringer Ingelheim Vetmedica GmbH

PEI.V.02996.01.1 28.10.2004 Schwein

Aftovaxpur DOE

Maul- und Klauenseuche

Boehringer Ingelheim Vetmedica GmbH

EU/2/13/153/001-850 15.07.2013 Rind, Schaf, Schwein

EPAR: Aftovaxpur DOE

BIOSUIS ParvoEry

Rotlauf, Parvovirose

Bioveta, a.s., Tschechien

PEI.V.12091.01.1 23.06.2021 Schwein

BIOSUIS Salm

Salmonellen-Infektion

Bioveta, a.s., Tschechien

PEI.V.11984.01.1 23.08.2019 Schwein

Suigen Entero 3

E. coli-Infektion, Rotavirus-Infektion, Clostridien-Infektion

Bioveta a.s., Tschechien

PEI.V.12174.01.1 29.04.2024 Schwein

Brucellin Aquilón

Hauttest zur Diagnose einer Brucella-Infektion

Aquilón Cyl S.L., Spanien

EU/2/22/291/001 26.01.2023 Schwein

EPAR: Brucellin Aquilón

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 530 in BAnz AT 16.06.2025 B4.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 17.06.2025